ATC 49th Executive Summary

49th Meeting of the WHO International Working Group For Drug Statistics Methodology

4 May 2021

| Publication

Overview

During the 49th ATC/DDD Consultation.

All new temporary ATC codes and alterations are published at the ATC/DDD Centre’s website and in WHO Drug Information (https://www.who.int/our-work/access-to-medicines-and-health-products/who-drug-information) with deadline for objections 1 September 2021.

finerenone
Monoclonal antibodies for the treatment of infections
Bacterial lysates
aducanumab
L01XC monoclonal antibodies
Fibroblast growth factor receptor tyrosine kinase inhibitors
semaglutide and liraglutide
lenacapavir
Dengue virus vaccines
Colchicine

Defined Daily Dose Items

Members accepted several new defined daily doses (DDD) proposed by the Centre. All new temporary DDDs and alterations are published at the ATC/DDD Centre’s website and in WHO Drug Information with deadline for objections 1 September 2021 (www.whocc.no).

WHO Team

INN and Classification of Medical Products (INN)

Editors

Programme on International Nonproprietary Names (INN)

Number of pages

Reference numbers

WHO Reference Number: INN Working Doc. 21.519